ANASPAZ

Product NDC
0225-0295
11-digit product format
002250295
Labeler code
0225
Product ID
0225-0295_5b5d2c46-5cd4-c6ef-e053-2991aa0adf32
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
HYOSCYAMINE SULFATE
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL; SUBLINGUAL
Labeler
BF ASCHER AND CO INC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
1973-01-02
Marketing end
0000-00-00
Substance
HYOSCYAMINE SULFATE
Active strength
0 mg/1
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0225-0295DDiscontinued by firm2026-08-11
excluded packagepackage0225-02950225-0295-15DDiscontinued by firm2026-08-11
excluded packagepackage0225-02950225-0295-20DDiscontinued by firm2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0225-0295-20d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0225-0295-15d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0225-0295-20f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0225-0295-15f5e01cc5f278…a2eaf40c39c3…

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0225-0295-15EA - Each0225-02956b0229cf-60a7-4b73-8c91-c9b9ce47ce3a12013-02-13
0225-0295-20EA - Each0225-02950dd9e7f8-c214-420f-923a-90f3a760b90712013-02-13

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0225-0295ANASPAZ (HYOSCYAMINE SULFATE) TABLET, ORALLY DISINTEGRATING [BF ASCHER AND CO INC]4Legacy NDC20240726_e5fd8476-418a-4149-a688-205ea943b30c.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0225-0295-1500225029515100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0225-0295-15) 1973-01-020000-00-00NoNoCurrent
0225-0295-2000225029520500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0225-0295-20) 1973-01-020000-00-00NoNoCurrent